SLC18A2
SLC18A2, also known as VMAT2, SVMT, SVAT or VAT2, is the synaptic vesicular amine transporter. It loads monoamines such as dopamine, serotonin, noradrenaline and histamine into secretory and synaptic vesicles ahead of release by exocytosis. Browse Assay Genie's current range of SLC18A2 research reagents below, or read on for the biology behind the target.
SLC18A2 is an electrogenic antiporter that exchanges one cationic monoamine for two intravesicular protons across the membrane of secretory and synaptic vesicles. It uses the electrochemical proton gradient established by the V-type proton-pump ATPase to accumulate monoamines at high concentration inside vesicles before they are released by exocytosis. By doing so it regulates the transvesicular monoaminergic gradient, which determines quantal size.
The transporter handles a broad set of substrates: catecholamines including dopamine, adrenaline and noradrenaline, histamine, and indolamines such as serotonin. In the striatum it acts as the primary transporter for dopamine loading, ensuring impulse-dependent release of dopamine at the synaptic cleft. It also mediates somatodendritic dopamine release in hippocampal neurons, likely as part of a regulated secretory pathway that integrates retrograde synaptic signals, and it is responsible for histamine and serotonin storage and subsequent corelease from mast cell granules.
The SLC18A2 gene encodes a transmembrane protein found in the membranes of synaptic and secretory vesicles, and in axons and dendrites. It belongs to the solute carrier family 18 and, by sequence, to the vesicular transporter family within the major facilitator superfamily. Its previous HGNC name was solute carrier family 18 (vesicular monoamine transporter), member 2. Polymorphisms in the gene may be associated with schizophrenia, bipolar disorder and other neurological and psychiatric conditions.
SLC18A2 is the main transporter loading dopamine into striatal vesicles, making it central to impulse-dependent dopamine release at the synapse.
By setting the transvesicular monoamine gradient, SLC18A2 determines quantal size, a key parameter in studies of vesicular filling and exocytosis.
Polymorphisms in the SLC18A2 gene may be associated with schizophrenia, bipolar disorder and other neurological and psychiatric ailments.
SLC18A2 is responsible for histamine and serotonin storage and corelease from mast cell granules, linking it to secretory granule biology.
SLC18A2 is an electrogenic antiporter that exchanges one cationic monoamine for two intravesicular protons. Powered by the proton gradient from the V-type proton-pump ATPase, it concentrates dopamine, noradrenaline, adrenaline, serotonin and histamine in secretory and synaptic vesicles before exocytosis.
SLC18A2 is widely called VMAT2, for vesicular monoamine transporter 2, and also SVMT, SVAT and VAT2. UniProt names the protein synaptic vesicular amine transporter. An earlier HGNC name was solute carrier family 18 (vesicular monoamine transporter), member 2.
Mouse and rat both have a Slc18a2 ortholog. NCBI Gene reports that polymorphisms in human SLC18A2 may be associated with schizophrenia, bipolar disorder and other neurological and psychiatric ailments. Check the datasheet of any product for its validated reactivity.
Other solute carrier family members, including SLC18A1 and neurotransmitter transporters, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q05940; product specifications from Assay Genie datasheets.